Dimensional Fund Advisors LP Invitae Corp Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$1.9 - $8.63 $307,575 - $1.4 Million	161,882 New	161,882 $398,000
Q1 2022 May 13, 2022	SELL	$6.28 - $15.59 $228,259 - $566,649	-36,347 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$14.7 - $28.67 $23,505 - $45,843	1,599 Added 4.6%	36,347 $555,000
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $32,575 - $45,024	1,340 Added 4.01%	34,748 $988,000
Q2 2021 Aug 12, 2021	SELL	$26.09 - $40.4 $2.96 Million - $4.58 Million	-113,396 Reduced 77.24%	33,408 $1.13 Million

Q1 2021 May 14, 2021	SELL	$33.06 - $56.93 $1.03 Million - $1.78 Million	-31,227 Reduced 17.54%	146,804 $5.61 Million
Q4 2020 Feb 25, 2021	BUY	$39.09 - $57.4 $6.96 Million - $10.2 Million	178,031 New	178,031 $7.44 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.